Chemotherapy Combination Boosts Overall Survival in Patients with EGFR-mutant Non-Small Cell Lung Cancer
Breast, Lung, and Bladder Cancer Phase 3 Trials led by Dana-Farber Presented at ESMO Congress 2025
Dana-Farber/Boston Children's Ranked Among the Best Pediatric Cancer Programs in the Nation for 19th Year in a Row
Clinical Trials Unite Doctors, Researchers, and Patients to Advance Treatments
Innovative Roswell Park Radiation Therapy Protocol in Lung Cancer to Be Highlighted at ASTRO Annual Meeting
Cracking the Code
New Diagnostic Tool Developed at Dana-Farber Revolutionizes Acute Leukemia Diagnosis
Dana-Farber Treats First Patient with Approved Gene Therapy for Beta Thalassemia
Clinical Trials and Research for Mantle Cell Lymphoma
New Research Sheds Light on Why Tamoxifen May Lead to Higher Risk of Uterine Cancer
Dana-Farber Researchers Find Less Treatment May be More in Mantle Cell Lymphoma
Weight Loss Trial Reports Success for Breast Cancer Patients at One Year Mark
New Strategy for Small Cell Lung Cancer Treatment Emerges from Dana-Farber Science
Dana-Farber Cancer Institute Unveils Groundbreaking Blood Test for Multiple Myeloma
Dana-Farber Cancer Institute, Boston Children’s Hospital, and Broad Clinical Labs Launch Precision Genomics Initiative for Pediatric Cancer
Showing 31 - 45 of 987 results
Previous| 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 ...66 |Next
Cancer
Cardiology
Gastroenterology
Neurology
OBGYN
Orthopedics
Pediatrics
BroadcastMed News
Dermatology
Diabetes & Endocrinology
Infectious Diseases
Ophthalmology
Optometry
Otolaryngology
Pulmonology
Surgery
Urology
About
Solutions
Resources
Contact
person Sign In / Create Account
